Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre

Published:2019-04-20 Issue:10 Volume:78 Page:1441-1443
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

You Hanxiao^ORCID,Zhang Guizhi,Wang Qian,Zhang Shangzhu,Zhao Jiuliang,Tian Xinping,Li Hongbin,Li Mengtao,Zeng Xiaofeng

Funder

Chinese National High Technology Research and Development Program, Ministry of Science and Technology

Chinese National Key Research R&D Program

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference6 articles.

1. The Jakinibs in systemic lupus erythematosus: progress and prospects;Mok;Expert Opin Investig Drugs,2019

2. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

3. Tofacitinib ameliorates murine lupus and its associated vascular dysfunction;Furumoto;Arthritis Rheumatol,2017

4. Tofacitinib can decrease anti-DNA antibody titers in inactive systemic lupus erythematosus complicated by rheumatoid arthritis;Yamamoto;Mod Rheumatol,2016

5. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial;Wallace;Lancet,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway;Phytomedicine;2024-10

2. Tofacitinib therapy in systemic lupus erythematosus with arthritis: a retrospective study;Clinical Rheumatology;2024-08-13

3. Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII;Lupus;2024-08-08

4. New and emerging therapies for systemic lupus erythematosus;Clinical Immunology;2024-06

5. Tofacitinib for the treatment of severe rare skin diseases: a narrative review;European Journal of Clinical Pharmacology;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3